Risk Assessment of Postoperative High Risk Population of Colorectal Cancer and Clinical Standardization of Jianpi Compound Intervention

ABSTRACT: Interventions: therapy group:Jianpi+ Western medicine chemotherapy; Control group: Placebo + Western medicine chemotherapy Primary outcome(s): Chinese medicine syndrome score;Quality of life;Safety-related physical and chemical indicators;Disease-free survival, DFS;overall survival, OS Study Design: Randomized parallel controlled trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2665573 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR